Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: Results from an early-stage randomized controlled trial

Journal of Consulting and Clinical Psychology

Volumn 82, Issue 3, 2014, Pages 448-459

  Garland, Eric L ^a   Manusov, Eron G ^b   Froeliger, Brett ^c   Kelly, Amber ^d   Williams, Jaclyn M ^e   Howard, Matthew O ^f  

^a UNIVERSITY OF UTAH   (United States)

^b Southern Regional Area Health Education Center   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SMITH COLLEGE   (United States)

^e FLORIDA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

addiction; chronic pain; cognitive reappraisal; mindfulness; opioid

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTHRITIS; ARTICLE; BRIEF PAIN INVENTORY; CERVICALGIA; CHRONIC PAIN; CONTROLLED STUDY; CURRENT OPIOID MISUSE MEASURE; DRUG MISUSE; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; INTERVENTION STUDY; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MINDFULNESS; MINDFULNESS ORIENTED RECOVERY ENHANCEMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOCICEPTION; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; STRESS; SUPPORT GROUP; AGED; AROUSAL; FEASIBILITY STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OPIOID-RELATED DISORDERS; PSYCHOLOGY; TREATMENT OUTCOME; UNITED STATES; VETERAN;

ADULT; AGED; ANALGESICS, OPIOID; AROUSAL; CHRONIC PAIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINDFULNESS; OPIOID-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES; VETERANS;

EID: 84901239293     PISSN: 0022006X     EISSN: 19392117     Source Type: Journal    
DOI: 10.1037/a0035798     Document Type: Article

References (67)

1. Alcaro, A., & Panksepp, J. (2011). The SEEKING mind: Primal neuroaffective substrates for appetitive incentive states and their pathological dynamics in addictions and depression. Neuroscience & Biobehavioral Reviews, 35, 1805-1820. doi:10.1016/j.neubiorev.2011.03.002
2. Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006). Using self-report assessment methods to explore facets of mindfulness. Assessment, 13, 27-45. doi:10.1177/1073191105283504 (Pubitemid 43812613)
3. Borkovec, T. D., & Nau, S. D. (1972). Credibility of analogue therapy rationales. Journal of Behavior Therapy and Experimental Psychiatry, 3, 257-260. doi:10.1016/0005-7916(72)90045-6
4. Bowen, S., Chawla, N., Collins, S. E., Witkiewitz, K., Hsu, S., Grow, J., & Marlatt, A. (2009). Mindfulness-based relapse prevention for substance use disorders: A pilot efficacy trial. Substance Abuse, 30, 295-305. doi:10.1080/08897070903250084
5. Butler, S. F., Budman, S. H., Fernandez, K. C., Houle, B., Benoit, C., Katz, N., & Jamison, R. N. (2007). Development and validation of the Current Opioid Misuse Measure. Pain, 130, 144-156. doi:10.1016/j.pain.2007.01.014 (Pubitemid 46843461)
6. Carlson, L. E., & Thomas, B. C. (2007). Development of the Calgary Symptoms of Stress Inventory (C-SOSI). International Journal of Behavioral Medicine, 14, 249-256. doi:10.1007/BF03003000 (Pubitemid 350250398)
7. Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Miaskowski, C. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain, 10, 113-130. doi:10.1016/j.jpain.2008.10.008
8. Chu, L. F., Angst, M. S., & Clark, D. (2008). Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clinical Journal of Pain, 24, 479-496. doi:10.1097/AJP.0b013e31816b2f43
9. Cleeland, C. S. (1994). Brief Pain Inventory-Short Form (BPI-SF). Houston, TX: University of Texas M. D. Anderson Cancer Center.
10. Durham, R., Chambers, J. A., MacDonald, R. R., Power, K. G., & Major, K. (2003). Does cognitive-behavioural therapy influence the long-Term outcome of generalized anxiety disorder? An 8-14 year follow-up of two clinical trials. Psychological Medicine, 33, 499-509. doi:10.1017/S0033291702007079
11. Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Zavisic, S. (2008). Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain, 9, 105-121. doi:10.1016/j.jpain.2007.09.005 (Pubitemid 351147828)
12. Eftekhari, A., Ruzek, J. I., Crowley, J. J., Rosen, C. S., Greenbaum, M. A., & Karlin, B. E. (2013). Effectiveness of national implementation of prolonged exposure therapy in Veterans Affairs care. JAMA: Journal of the American Medical Association Psychiatry, 70, 949-955. doi: 10.1001/ jamapsychiatry.2013.36
13. Erdfelder, E., Faul, F., & Buchner, A. (1996). GPOWER: A general power analysis program. Behavior Research Methods, Instruments, & Computers, 28, 1-11.
14. Fishbain, D. A., Cole, B., Lewis, J., Rosomoff, H. L., & Rosomoff, R. S. (2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Medicine, 9, 444-459. doi:10.1111/j.1526-4637.2007.00370.x (Pubitemid 351722518)
15. Frison, L., & Pocock, S. J. (1992). Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design. Statistics in Medicine, 11, 1685-1704. doi:10.1002/sim.4780111304
16. Garland, E. L. (2012). Pain processing in the human nervous system: A selective review of nociceptive and biobehavioral pathways. Primary Care: Clinics in Office Practice, 39, 561-571. doi:10.1016/j.pop.2012.06.013
17. Garland, E. L. (2013). Mindfulness-Oriented Recovery Enhancement for addiction, stress, and pain. Washington, DC: National Association of Social Workers.
18. Garland, E. L., Boettiger, C. A., & Howard, M. O. (2011). Targeting cognitive-Affective risk mechanisms in stress-precipitated alcohol dependence: An integrated, biopsychosocial model of allostasis, automaticity, and addiction. Medical Hypotheses, 76, 745-754. doi:10.1016/j.mehy.2011.02.014
19. Garland, E. L., Fredrickson, B. L., Kring, A. M., Johnson, D. P., Meyer, P. S., & Penn, D. L. (2010). Upward spirals of positive emotions counter downward spirals of negativity: Insights from the broaden-And-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathology. Clinical Psychology Review, 30, 849-864. doi:10.1016/j.cpr. 2010.03.002
20. Garland, E. L., Froeliger, B. E., & Howard, M. O. (2013a). Mindfulness training targets neurocognitive mechanisms of addiction at the attentionappraisal-emotion interface. Frontiers in Psychiatry, 4, 173. doi: 10.3389/fpsyt.2013.00173
21. Garland, E. L., Froeliger, B. E., & Howard, M. O. (2013b). Mindfulness-Oriented Recovery Enhancement reduces opioid craving by restructuring reward responsiveness. Manuscript submitted for publication.
22. Garland, E. L., Froeliger, B. E., Passik, S. D., & Howard, M. O. (2013). Attentional bias for prescription opioid cues among opioid-dependent chronic pain patients. Journal of Behavioral Medicine, 36, 611-620. doi:10.1007/s10865-012-9455-8
23. Garland, E. L., Froeliger, B., Zeidan, F., Partin, K., & Howard, M. O. (2013). The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways. Neuroscience & Biobehavioral Reviews, 37, 2597-2607. doi: 10.1016/j.neubiorev.2013.08.006
24. Garland, E. L., Gaylord, S. A., Boettiger, C. A., & Howard, M. O. (2010). Mindfulness training modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: Results from a randomized controlled pilot trial. Journal of Psychoactive Drugs, 42, 177-192. doi:10.1080/02791072.2010.10400690
25. Garland, E. L., Gaylord, S. A., & Fredrickson, B. L. (2011). Positive reappraisal coping mediates the stress-reductive effect of mindfulness: An upward spiral process. Mindfulness, 2, 59-67. doi:10.1007/s12671-011-0043-8
26. Garland, E. L., Gaylord, S. A., Palsson, O., Faurot, K., Mann, J. D., & Whitehead, B. (2012). Therapeutic mechanisms of a mindfulness-based treatment for irritable bowel syndrome: Effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. Journal of Behavioral Medicine, 35, 591-602. doi:10.1007/s10865-011-9391-z
27. Garland, E. L., & Howard, M. O. (2013). Mindfulness-Oriented Recovery Enhancement reduces pain attentional bias in chronic pain patients. Psychotherapy and Psychosomatics, 82, 311-318. doi:10.1159/000348868
28. Garnefski, N., & Kraaij, V. (2007). The cognitive emotion regulation questionnaire: Psychometric features and prospective relationships with depression and anxiety in adults. European Journal of Psychological Assessment, 23, 141-149. doi:10.1027/1015-5759.23.3.141
29. Gaylord, S. A., Palsson, O. S., Garland, E. L., Faurot, K. R., Coble, R. S., Mann, J. D., Whitehead, W. E. (2011). Mindfulness training reduces the severity of irritable bowel syndrome in women: Results of a randomized controlled trial. American Journal of Gastroenterology, 106, 1678-1688. doi:10.1038/ajg.2011.184
30. Goldstein, R. Z., Craig, A. D., Bechara, A., Garavan, H., Childress, A. R., Paulus, M. P., & Volkow, N. D. (2009). The neurocircuitry of impaired insight in drug addiction. Trends Cognitive in Sciences, 13, 372-380. doi:10.1016/j.tics.2009.06.004
31. Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004). Mindfulness-based stress reduction and health benefits. A meta-Analysis. Journal of Psychosomatic Research, 57, 35-43. doi:10.1016/S0022-3999(03)00573-7 (Pubitemid 38901093)
32. Hofmann, S. G., Sawyer, A. T., Witt, A. A., & Oh, D. (2010). The effect of mindfulness-based therapy on anxiety and depression: A metaanalytic review. Journal of Consulting and Clinical Psychology, 78, 169-183. doi:10.1037/a0018555
33. Højsted, J., Nielsen, P. R., Guldstrand, S. K., Frich, L., & Sjøgren, P. (2010). Classification and identification of opioid addiction in chronic pain patients. European Journal of Pain, 14, 1014-1020. doi:10.1016/j.ejpain.2010.04.006
34. Hurwitz, B. E., Klaus, J. R., Llabre, M. M., Gonzalez, A., Lawrence, P. J., Maher, K. J., Schneiderman, N. (2007). Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Archives of Internal Medicine, 167, 148-154. doi:10.1001/archinte.167.2. 148 (Pubitemid 46148061)
35. Jamison, R. N., Ross, E. L., Michna, E., Chen, L. Q., Holcomb, C., & Wasan, A. D. (2010). Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A randomized trial. Pain, 150, 390-400. doi:10.1016/j.pain.2010.02.033
36. Jamison, R. N., Serrailier, J., & Michna, E. (2011). Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Research & Treatment, 2011, Article ID 941808. doi:10.1155/2011/941808
37. Jänig, W. (1995). The sympathetic nervous system in pain. European Journal of Anaesthesiology Supplement, 10, 53-60.
38. Kabat-Zinn, J. (1982). An outpatient program in behavioral medicine for chronic pain patients based on the practice on mindfulness meditation: Theoretical considerations and preliminary results. General Hospital Psychiatry, 4, 33-47. doi:10.1016/0163-8343(82)90026-3 (Pubitemid 12088404)
39. Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4, 231-244. doi:10.3109/10673229709030550
40. Kirsh, K. L., Jass, C., Bennett, D. S., Hagen, J. E., & Passik, S. D. (2007). Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliative & Supportive Care, 5, 219-226. doi:10.1017/S1478951507000387
41. Kober, H., Mende-Siedlecki, P., Kross, E. F., Weber, J., Mischel, W., Hart, C. L., & Ochsner, K. N. (2010). Prefrontal-striatal pathway underlies cognitive regulation of craving. PNAS: Proceedings of the National Academy of the Sciences of the United States of America, 107, 14811-14816. doi:10.1073/pnas.1007779107
42. Koob, G. F., & Le Moal, M. (2008). Neurobiological mechanisms for opponent motivational processes in addiction. Philosophical Transactions of the Royal Society, Section B: Biological Sciences, 363, 3113-3123. doi:10.1098/rstb.2008.0094
43. Larson, M., Paasche-Orlow, M., Cheng, D., Lloyd-Travaglini, C., Saitz, R., & Samet, J. (2007). Persistent pain is associated with substance use after detoxification: A prospective cohort analysis. Addiction, 102, 752-760. doi:10.1111/j.1360-0443.2007.01759.x (Pubitemid 46633356)
44. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Segal, D. (1998). Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction, 93, 475-486. doi:10.1046/j.1360-0443.1998.9344753.x (Pubitemid 28188067)
45. Little, R. J. A. (1988). A test of missing completely at random for multivariate data with missing values. Journal of the American Statistical Association, 83, 1198-1202. doi:10.1080/01621459.1988.10478722
46. Lubman, D. I., Allen, N. B., Peters, L. A., & Deakin, J. F. (2007). Electrophysiological evidence of the motivational salience of drug cues in opiate addiction. Psychological Medicine, 37, 1203-1209. doi: 10.1017/S0033291707009932 (Pubitemid 47209122)
47. Lubman, D. I., Allen, N. B., Peters, L. A., & Deakin, J. F. (2008). Electrophysiological evidence that drug cues have greater salience than other affective stimuli in opiate addiction. Journal of Psychopharmacology, 22, 836-842. doi:10.1177/0269881107083846
48. Lubman, D. I., Yucel, M., Kettle, J. W., Scaffidi, A., Mackenzie, T., Simmons, J. G., & Allen, N. B. (2009). Responsiveness to drug cues and natural rewards in opiate addiction: Associations with later heroin use. Archives of General Psychiatry, 66, 205-213. doi:10.1001/archgenpsychiatry.2008. 522
49. Martell, B. A., O'Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., & Fiellin, D. A. (2007). Systematic review: Opioid treatment for chronic back pain. Prevalence, efficacy, and association with addiction. Annals of Internal Medicine, 146, 116-127. doi:10.7326/0003-4819-146- 2-200701160-00006
50. Martenson, M. E., Cetas, J. S., & Heinricher, M. M. (2009). A possible neural basis for stress-induced hyperalgesia. Pain, 142, 236-244. doi: 10.1016/j.pain.2009.01.011
51. Meltzer, E. C., Rybin, D., Saitz, R., Samet, J. H., Schwartz, S. L., Butler, S. F., & Liebschutz, J. M. (2011). Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain, 152, 397-402. doi:10.1016/j.pain.2010.11.006
52. Ochsner, K. N., & Gross, J. J. (2005). The cognitive control of emotion. Trends in Cognitive Sciences, 9, 242-249. doi:10.1016/j.tics.2005.03. 010 (Pubitemid 40615112)
53. Oliver, J., Coggins, C., Compton, P., Hagan, S., Matteliano, D., Stanton, M., Turner, H. N. (2012). American Society for Pain Management Nursing position statement: Pain management in patients with substance use disorders. Pain Management Nursing, 13, 169-183. doi:10.1016/j.pmn.2012.07.001
54. Rawson, R., & McCann, M. J. (2006). Counselor's treatment manual: Matrix intensive outpatient treatment for people with stimulant use disorders (DHHS Publication No. SMA 06-4152). Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration.
55. Ren, Z. Y., Shi, J., Epstein, D. H., Wang, J., & Lu, L. (2009). Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology, 204, 423-429. doi:10.1007/s00213-009-1472-0
56. Robinson, T. E., & Berridge, K. C. (2008). Review. The incentive sensitization theory of addiction: Some current issues. Philosophical Trans-Actions of the Royal Society of London, Series B: Biological Sciences, 363, 3137-3146. doi:10.1098/rstb.2008.0093
57. Rogers, C. (2003). Client-centered therapy: Its current practice, implications, and theory. New York, NY: Constable.
58. Rosenstiel, A. K., & Keefe, F. J. (1983). The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment. Pain, 17, 33-44. doi:10.1016/0304- 3959(83)90125-2 (Pubitemid 13004472)
59. Rosenzweig, S., Greeson, J. M., Reibel, D. K., Green, J. S., Jasser, S. A., & Beasley, D. (2010). Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice. Journal of Psychosomatic Research, 68, 29-36. doi:10.1016/j. jpsychores.2009.03.010
60. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M. I. N. I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl, 20), 22-33. (Pubitemid 29001829)
61. Stacy, A. W., & Wiers, R. W. (2010). Implicit cognition and addiction: A tool for explaining paradoxical behavior. Annual Review of Clinical Psychology, 6, 551-575. doi:10.1146/annurev.clinpsy.121208.131444
62. Wasan, A. D., Butler, S. F., Budman, S. H., Fernandez, K., Weiss, R. D., Greenfield, S. F., & Jamison, R. N. (2009). Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clinical Journal of Pain, 25, 193-198. doi:10.1097/AJP.0b013e318193a6c4
63. Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., Ling, W. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry, 68, 1238-1246. doi:10.1001/archgenpsychiatry.2011.121
64. Weiss, R. D., Potter, J. S., Provost, S. E., Huang, Z., Jacobs, P., Hasson, A., Ling, W. (2010). A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemporary Clinical Trials, 31, 189-199. doi:10.1016/j.cct.2010.01.003
65. Williams, A., Eccleston, C., & Morley, S. (2012). Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Systematic Reviews, 11. Article No. CD007407. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/14651858/CD007407.pub3/pdf/standard
66. Witkiewitz, K., Bowen, S., Douglas, H., & Hsu, S. H. (2013). Mindfulnessbased relapse prevention for substance craving. Addictive Behaviors, 38, 1563-1571. doi:10.1016/j.addbeh.2012.04.001
67. Zeidan, F., Martucci, K. T., Kraft, R. A., Gordon, N. S., McHaffie, J. G., & Coghill, R. C. (2011). Brain mechanisms supporting the modulation of pain by mindfulness meditation. Journal of Neuroscience, 31, 5540-5548. doi:10.1523/JNEUROSCI.5791-10.2011